

709: John Abramson | How Big Pharma Broke American Health Care
Aug 9, 2022
Dr. John Abramson, a Harvard Medical School physician and author, dives into the troubling relationship between Big Pharma and American healthcare. He reveals how the U.S. spends over $1.6 trillion on healthcare yet ranks low in health quality. Abramson highlights the industry's profit-centric priorities, including controlling clinical trials and withholding critical data. He also discusses the need for reform to shift focus from profits to patient care, emphasizing lifestyle choices over pharmaceuticals for better health outcomes.
AI Snips
Chapters
Books
Transcript
Episode notes
Declining Life Expectancy
- American life expectancy is decreasing, especially compared to other developed nations.
- Healthcare spending is rising, but health outcomes are worsening.
Pharma Advertising and Oversight
- The US and New Zealand are the only countries allowing direct-to-consumer pharmaceutical advertising.
- However, New Zealand has stricter oversight and a national pharma plan, unlike the US.
Marketing Beyond Advertising
- Drug company marketing includes research agendas, study design, and data analysis control.
- Publications often become marketing material, influencing doctors' perceptions of evidence-based medicine.